SYT5: A Potential Drug Target for Neurological Disorders (G6861)

Target Name: SYT5

NCBI ID: G6861

SYT5: A Potential Drug Target for Neurological Disorders

Synaptotagmin 5 (SYT5) is a protein that is expressed in the central nervous system (CNS) and has been identified as a potential drug target for various neurological disorders, including Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. SYT5 has also been shown to be involved in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time.

SYT5 is a transmembrane protein that is expressed in the CNS and is involved in the regulation of various cellular processes, including neuronal communication and synaptic plasticity. It is a member of the synaptotagmin family, which includes other proteins that are involved in the regulation of synaptic plasticity, including SYT1 and SYT2.

SYT5 has been shown to play a role in the regulation of synaptic plasticity in various parts of the brain, including the prefrontal cortex, which is responsible for various higher-order cognitive functions, and the hippocampus, which is involved in the regulation of memory and emotion.

SYT5 has also been shown to be involved in the regulation of neurotransmitter release, which is the release of chemical messengers from neurons that help to communicate with other neurons and with the endosteum, the lining of the blood vessels. This is important for the regulation of synaptic plasticity and the development of various neurological disorders.

SYT5 has also been shown to be involved in the regulation of cell survival, which is the ability of cells to continue to exist and function over time. This is important for the regulation of tissues and organs, including the brain, which is responsible for many of the higher-order functions that we rely on for our daily lives.

SYT5 has also been shown to play a role in the regulation of inflammation, which is the immune response of the body to harmful substances. This is important for the regulation of various autoimmune disorders, including Alzheimer's disease, which is characterized by the accumulation of immune cells in the brain that cause neurodegeneration.

In conclusion, SYT5 is a protein that is involved in various cellular processes in the CNS, including the regulation of synaptic plasticity, neurotransmitter release, cell survival, and inflammation. As a potential drug target, SYT5 is a promising target for the development of new treatments for a variety of neurological disorders. Further research is needed to fully understand the role of SYT5 in the regulation of synaptic plasticity and the development of neurological disorders.

Protein Name: Synaptotagmin 5

Functions: May be involved in Ca(2+)-dependent exocytosis of secretory vesicles through Ca(2+) and phospholipid binding to the C2 domain or may serve as Ca(2+) sensors in the process of vesicular trafficking and exocytosis. Regulates the Ca(2+)-dependent secretion of norepinephrine in PC12 cells. Required for export from the endocytic recycling compartment to the cell surface (By similarity)

More Common Targets